Showing 2311-2320 of 4651 results for "".
New Products and Pharmacological Developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacological-developments/20429/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20634/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-29/23622/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20551/Update on Human Safety and the Environmental Impact of Physical and Chemical Sunscreen Filters
https://practicaldermatology.com/topics/skin-cancer-photoprotection/update-on-human-safety-and-the-environmental-impact-of-physical-and-chemical-sunscreen-filters/20800/What do we know about the effects of these commonly used and important molecules?Indoor Tanning Beds: The Dangers of Adolescent Tanning
https://practicaldermatology.com/topics/skin-cancer-photoprotection/indoor-tanning-beds-the-dangers-of-adolescent-tanning/22972/As research continues to shed light on the connection between UV exposure and skin cancer, greater efforts are required to inform the public and affect the legislative process.The Role of Hypnosis in Dermatology: More than Mere Suggestion
https://practicaldermatology.com/columns/clinical-focus-1/the-role-of-hypnosis-in-dermatology-more-than-mere-suggestion/23240/Hypnosis has shown promising results for patients who have had difficulty responding to more conventional therapies.Diagnosing and Managing Hair Disorders
https://practicaldermatology.com/topics/general-topics/diagnosing-and-managing-hair-disorders/20624/From loss to overgrowth, hair disorders may be associated with systemic causes.Lupus erythematosus tumidus vs Jessner's lymphocytic infiltrate of the Skin
https://practicaldermatology.com/topics/general-topics/lupus-erythematosus-tumidus-vs-jessners-lymphocytic-infiltrate-of-the-skin/21686/A systematic comparison of clinical and histologic characteristics.Cutaneous T-Cell Lymphoma: Mogamulizumab as a Novel Treatment for Refractory Mycosis Fungoides and Sezary Syndrome
https://practicaldermatology.com/youngmd-connect/resident-resource-center/Cutaneous-T-Cell-Lymphoma-Mogamulizumab-as-a-Novel-Treatment-for-Refractory-Mycosis-Fungoides-and-Sezary-Syndrome/23409/An overview of the diagnosis and prognosis of CTCL.